Patent: 9,937,183
✉ Email this page to a colleague
Summary for Patent: 9,937,183
| Title: | Antimicrobial compounds and methods of making and using the same |
| Abstract: | Methods and compounds for treating, preventing, reducing the risk of and/or delaying the onset of a microbial infection in a subject are disclosed herein, wherein the microbial infection is caused by one or more microorganisms (e.g., one or more bacteria) which can be used as a biological weapon, such as Bacillus anthracis, Franciscella tularensis, Yersinia pestis, Burkholderia mallei, and Burkholderia pseudomallei. Also disclosed are pharmaceutical compositions or kits for treating, preventing, reducing the risk of and/or delaying the onset of a microbial infection. |
| Inventor(s): | Kanyo; Zoltan F. (New Haven, CT), Bhattacharjee; Ashoke (New Haven, CT) |
| Assignee: | Melinta Therapeutics, Inc. (New Haven, CT) |
| Application Number: | 14/917,920 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,937,183
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Emergent Biodefense Operations Lansing Llc | BIOTHRAX | anthrax vaccine adsorbed | Injection | 103821 | 11/12/1998 | ⤷ Try a Trial | 2033-09-09 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
